1016eTiP A first-in-human phase I study of LY4066434, a potent and orally bioavailable pan-KRAS inhibitor, in KRAS-mutant solid tumors (Trial in Progress)
作者
S. Kitano,Amita Patnaik,V. Subbiah,T. Koyama,A. Parikh,R. Yaeger,B. Herzberg,Rachel Galot,J-H. Lee,Elena Garralda,Davide Melisi,T.O. Goetze,Philippe Alexandre Cassier,Jian Li,Matthew P. Hanley,Jennifer A. Wright,Aimee K. Bence,Magnus Axelson,Nehal J. Lakhani
PDF的下载单位、IP信息已删除
(2025-6-4)
null
GingerF
吃葡萄不吐葡萄皮
渡人舟
Criminology34
C.Cat
学霸业
n01W97
无极微光
学术雷锋
清风徐来
机智的白卉
俊逸的映易
Mic
auqkhter
June
秋风
v0id
sanvva
123
皖公网安备34019202002308
